Johnson Wendy S.
- SEC CIK
- 0001652822
No open-market purchases or sales filed in the past year.
Current role at each company
- XGN Exagen Inc.Directoras of Jun 13, 2023
- OKUR OnKure Therapeutics, Inc.Chief Development Officeras of Jul 15, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Johnson Wendy S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
XGN Exagen Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2021 (view filing) | Sep 3 | 4 days | Johnson Wendy S.Director | PPurchase | +1.00K | $14.02 | +$14.0K | New position1.00K after |
OKUR OnKure Therapeutics, Inc.
Chief Development Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 15, 2021 (view filing) | Jul 14 | 1 day | Johnson Wendy S.Chief Development Officer | SSale | −111.7K | $8.50 | −$949.8K | −100.0%0 after |